*P71934A0128*
Turn over     
P71934A
©2023 Pearson Education Ltd.
N:1/1/1/1/1/1/


Please check the examination details below before entering your candidate information 
Candidate surname
Other names
Centre Number
Candidate Number
Pearson Edexcel International Advanced Level
Monday 8 May 2023
Morning (Time: 1 hour 30 minutes)
WBI11/01
Paper
reference 
Total Marks  
Biology
Advanced Subsidiary/Advanced Level
UNIT 1: Molecules, Diet, Transport and Health
You must have:
Scientific calculator, ruler, HB pencil 
Instructions
•	Use black ink or ball-point pen.
•	Fill in the boxes at the top of this page with your name,  
centre number and candidate number.
•	Answer all questions.
•	Answer the questions in the spaces provided  
– there may be more space than you need.
•	Show all your working out in calculations and include units where appropriate.
Information
•	The total mark for this paper is 80.
•	The marks for each question are shown in brackets 
– use this as a guide as to how much time to spend on each question.
•	Questions labelled with an asterisk (*) are ones where the quality of your written 
communication will be assessed – you should take particular care on these 
questions with your spelling, punctuation and grammar, as well as the clarity 
of expression.
Advice
•	Read each question carefully before you start to answer it.
•	Try to answer every question.
•	Check your answers if you have time at the end.
PMT


--- Page Break ---

*P71934A0228*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
2
 
 
Answer ALL questions.
Write your answers in the spaces provided.
Some questions must be answered with a cross in a box . If you change your mind about an 
answer, put a line through the box 
 and then mark your new answer with a cross .
1	 Messenger RNA (mRNA) and transfer RNA (tRNA) are involved in protein synthesis.
	
(a)	 The diagram shows the sequence of bases in part of a DNA template 
(antisense) strand and the mRNA molecule formed during protein synthesis.
A
T
G
C
C
G
T
T
DNA template strand
mRNA
	
	
(i)	 Complete the diagram to show the sequence of bases in this mRNA.
(1)
	
	
(ii)	 Name this stage of protein synthesis.
(1)
....................................................................................................................................................................................................................................................................................
	
	
(iii)	 Name the enzyme used in this stage of protein synthesis.
(1)
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P71934A0328*
Turn over     
3
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
	
(b)	 The diagram shows part of a tRNA molecule.
	
	 Compare and contrast the structure of an mRNA molecule with that of a 
tRNA molecule.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 1 = 6 marks)
PMT


--- Page Break ---

*P71934A0428*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
4
 
 
2	 The graphs show how the pressure and volume of blood in the left ventricle change 
during the cardiac cycle.
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
20
16
12
8
4
0
Time / seconds
Pressure in 
left ventricle 
/ kPa
P
Q
R
S
0.1
0.3
0.5
0.7
0.9
1.1
1.3
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Time / seconds
130
110
90
70
50
0
Volume of 
blood in left 
ventricle / 
cm3
	
(a)	 Which letter indicates when the atrioventricular (mitral) valves close?
(1)
	
A	 P
	
B	 Q
	
C	 R
	
D	 S
	
(b)	 Calculate the time for one cardiac cycle.
(1)
Answer .............................................................. seconds
PMT


--- Page Break ---

*P71934A0528*
Turn over     
5
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
	
(c)	 The volume of blood in the left ventricle changes during the cardiac cycle.
	
	 Explain these changes.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 2 = 5 marks)
PMT


--- Page Break ---

*P71934A0628*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
6
 
 
3	 Sucrose is a disaccharide made from glucose and fructose.
	
Glucose is joined to fructose by a 1–2 glycosidic bond.
	
(a)	 (i)	 The diagram shows a molecule of glucose and a molecule of fructose.
	
	
	 Carbon 1 on the glucose and carbon 2 on the fructose are numbered.
	
	
	 Complete the diagram to show a glycosidic bond between the glucose 
molecule and the fructose molecule.
(1)
H
CH2OH
 O
1
2
HOH2C
O
H
CH2OH
	
	
(ii)	 Complete the formula equation for the reaction that makes sucrose from 
glucose and fructose.
(2)
C6H12O6  +  C6H12O6  
	
(b)	 The concentration of sucrose in a solution can be determined by a test.
	
	 The chart shows the steps involved in this test.
Break sucrose down into glucose and fructose using an enzyme
Add a chemical that binds to fructose and changes colour
Measure the colour intensity of the solution
PMT


--- Page Break ---

*P71934A0728*
Turn over     
7
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
	
	 The colour intensity is directly proportional to the concentration of sucrose.
	
	 The graph shows this relationship.
2000
1500
1000
500
0
0.6
0.4
0.2
0.0
Colour intensity 
/ a.u.
Concentration of sucrose / µg dm–3
	
	
(i)	 Give a reason why the colour intensity is directly proportional to the 
concentration of sucrose.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(ii)	 Suggest why the line does not start at the origin of the graph.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(iii)	 State why the concentration of maltose and lactose cannot be measured 
using this test.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 3 = 6 marks)
PMT


--- Page Break ---

*P71934A0828*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
8
 
 
4	 Hydra are small animals that live in water.
	
They have a cylindrical body.
	
The drawing shows a hydra.
body
	
(a)	 This hydra has a body length of 1.8 mm and a diameter of 1 mm.
	
	
(i)	 Which is the magnification of this drawing?
(1)
	
A	 3.75 × 10–2
	
B	 3.75 × 10–1
	
C	 2.67 × 100
	
D	 2.67 × 101
	
	
(ii)	 Which is the surface area, in mm2, of this hydra?
	
	
	 Use the formula:
	
	
	 surface area = 2πrl
(1)
	
A	 0.9 π
	
B	 1.8 π
	
C	 3.6 π
	
D	 5.4 π
PMT


--- Page Break ---

*P71934A0928*
Turn over     
9
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
	
	
(iii)	 Another hydra has a surface area of 2.3 π mm2, a body length of 1.8 mm and a 
diameter of 1.2 mm.
	
	
	 Calculate the surface area to volume ratio of this hydra.
	
	
	 Use the formula:
	
	
	 volume = πr2l
(2)
Answer ..............................................................
	
(b)	 A hydra has a hollow body that is made up of two layers of cells.
	
	 Explain how a hydra is adapted for gas exchange.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 4 = 7 marks)
PMT


--- Page Break ---

*P71934A01028*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
10
 
 
5	 Stents are used in the treatment of atherosclerosis.
	
Stents widen the diseased coronary artery so that blood can flow through to the 
heart muscle.
	
The diagram shows a stent.
stent
diseased coronary artery
	
Stents can damage the endothelial cells lining the artery and trigger the formation of 
a blood clot.
	
Patients who have a stent fitted are given anticoagulants.
	
(a)	 Explain how damage to the endothelial cells results in the formation of thrombin.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(b)	 Give one risk of treating patients with anticoagulants.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P71934A01128*
Turn over     
11
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
	
(c)	 The photograph shows a tropical bont tick.
(Source: © Phanie/Alamy Stock Photo)
	
	 This bont tick produces a peptide called variegin.
	
	 Variegin binds to the active site of thrombin and prevents blood clotting.
	
	
(i)	 Variegin is a peptide consisting of 32 amino acids.
	
	
	 Which is the minimum number of bases in the gene that codes for 
this peptide?
(1)
	
A	 32
	
B	 33
	
C	 96
	
D	 99
	
	
(ii)	 Explain how variegin prevents blood clotting.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P71934A01228*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
12
 
 
	
	
(iii)	 Thrombin slowly splits variegin into two molecules.
	
	
	 Explain how thrombin splits variegin.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P71934A01328*
Turn over     
13
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
	
	
(iv)	 The effect of variegin on the mass of blood clots forming inside a stent 
was investigated.
	
	
	 The masses were compared with another anticoagulant, drug H.
	
	
	 The graph shows the results of this investigation.
	
	
	 Each plotted point represents the mass of blood clot in one stent.
variegin
drug H
125
100
75
50
25
0
Mass of blood clot  
/ mg
	
	
	 Comment on the results of this investigation.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 5 = 10 marks)
PMT


--- Page Break ---

*P71934A01428*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
14
 
 
6	 Insects and other invertebrates are a good source of protein, unsaturated fatty acids, 
iron and other nutrients.
	
Recent research has shown that some insects and other invertebrates have a high 
antioxidant content.
	
(a)	 How many of the following statements are true for proteins?
•	
Proteins contain only the elements carbon, hydrogen and nitrogen.
•	
Proteins can be made of more than one polypeptide chain.
•	
Proteins contain hydrogen bonds.
(1)
	
A	 0
	
B	 1
	
C	 2
	
D	 3
	
(b)	 Which row of the table is correct for an unsaturated fatty acid?
(1)
	
A	
	
B	
	
C	
	
D	
Contains carbon–carbon 
double bonds
Carbon : hydrogen ratio 
compared with a saturated 
fatty acid is
no
lower
no
higher
yes
lower
yes 
higher
	
(c)	 Name one organic molecule that contains iron.
(1)
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P71934A01528*
Turn over     
15
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
	
(d)	 Explain why dietary antioxidants are important.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P71934A01628*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
16
 
 
	
(e)	 The antioxidant activity of some insects and arachnids was investigated.
	
	 The table shows the dietary habits of the organisms used in this investigation.
Name of organism
Type of organism
Dietary habits
Black tarantulas
arachnid
eat animals
Black scorpions
arachnid
eat animals
Giant water bugs
insect
eat animals
Silkworms
insect
eat plants
Crickets
insect
eat plants
African caterpillars
insect
eat plants
Grasshoppers
insect
eat plants
	
	 The graph shows the mean antioxidant activity of extracts made from 
these organisms.
Black tarantulas
Black scorpions
Giant water bugs
Silkworms
Crickets
African caterpillars
Grasshoppers
2.5
2.0
1.5
1.0
0.5
0.0
Mean  
antioxidant 
activity  
/ a.u. per 100 g
PMT


--- Page Break ---

*P71934A01728*
Turn over     
17
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
	
	
(i)	 The antioxidant activity of orange juice is 0.80 a.u. per 100 g.
	
	
	 Calculate how many times more antioxidant activity there is in 100 g of 
grasshopper extract.
	
	
	 Give your answer to two significant figures.
(1)
Answer ..............................................................
	
	
(ii)	 Calculate the percentage difference between the antioxidant activity in black 
scorpions and crickets.
(1)
Answer ..............................................................%
	
	
(iii)	 Comment on the results of this investigation.
	
	
	 Use the information in the table and the graph to support your answer.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 6 = 12 marks)
PMT


--- Page Break ---

*P71934A01828*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
18
 
 
BLANK PAGE
PMT


--- Page Break ---

*P71934A01928*
Turn over     
19
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
7	 Prenatal testing is used to screen for genetic disorders in developing embryos.
	
(a)	 Phenylketonuria (PKU) is one genetic disorder that is screened for by 
prenatal testing.
	
	 This disorder is inherited in a similar way to cystic fibrosis.
	
	 Explain why a healthy couple might choose to have a prenatal test for PKU.
	
	 Draw a genetic diagram in your answer.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P71934A02028*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
20
 
 
	 *(b)	 A group of women, who had recently given birth to healthy babies, were asked 
about their opinions on screening for four different genetic disorders,  
A, B, C and D.
	
	 They were asked three questions about each disorder:
	
	 1  Would they be screened themselves with a blood test?
	
	 2  Would they have amniocentesis to screen for the genetic disorders?
	
	 3  Would they have a pregnancy termination (abortion) if an unborn child was 
found to have the genetic disorder?
	
	 The graph shows the percentage of women who said yes to each question for 
each disorder.
100
80
60
40
20
0
Disorder A
Disorder B
Disorder C
Disorder D
Percentage of 
women saying 
yes to the 
question (%)
Key
blood test 
    amniocentesis 
    termination 
	
	 The table gives some information about each of these genetic disorders.
Genetic disorder
Information
A
muscles are weak and movement is difficult
symptoms can be managed
some types are lethal in childhood
B
treatable
does not shorten life expectancy
C
treatable
most individuals live into adulthood
D
intellectual disability
medical care results in individuals leading healthy lives
PMT


--- Page Break ---

*P71934A02128*
Turn over     
21
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
	
	 Discuss the responses to the three questions.
(6)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 7 = 10 marks)
PMT


--- Page Break ---

*P71934A02228*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
22
 
 
8	 The risk of developing cardiovascular disease (CVD) is influenced by a number 
of factors.
	
Risk assessment calculators allow a person to calculate their own risk of 
developing CVD.
	
The person completes a questionnaire about their health and lifestyle. This 
information is then used to calculate the risk of the person developing CVD within 
the next ten years.
	
The table shows the information required by two different risk assessment calculators, 
RAC-1 and RAC-2.
Information
Information required by the calculators
RAC-1
RAC-2
Age


Blood pressure


Smoking

x
Total cholesterol


HDL cholesterol
x

	
(a)	 How many of the risk factors listed in the table are not influenced by lifestyle?
(1)
	
A	 1
	
B	 2
	
C	 3
	
D	 4
PMT


--- Page Break ---

*P71934A02328*
23
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
Turn over     
	
*(b)	 Explain the effectiveness of these two calculators in the assessment of risk and 
whether other factors should be considered.
(6)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P71934A02428*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
24
 
 
	
(c)	 The calculators work out the risk of a person developing CVD in the next 10 years.
	
	
(i)	 Explain why the information entered by a person may lead to an 
underestimate of their 10-year risk of developing CVD.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(ii)	 Suggest why these two risk calculators may not be suitable for everybody 
to use.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(iii)	 Suggest why these risk calculators estimate the 10-year risk of 
developing CVD.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 8 = 12 marks)
PMT


--- Page Break ---

*P71934A02528*
Turn over     
25
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
9	 Some marine animals are osmoconformers and some are osmoregulators.
	
Strict osmoconformers have a cell solute concentration that matches the solute 
concentration of the sea water.
	
Partial osmoconformers have a cell solute concentration that varies with the solute 
concentration of the sea water. 
	
Osmoregulators control the solute concentration of their cells when the solute 
concentration of sea water changes.
	
(a)	 The graph shows the solute concentration of the cells of three marine animals, 
P, Q and R.
Solute concentration of sea water
Solute 
concentration 
of the cells
P
Q
R
	
	
(i)	 Which row in the table identifies the marine animals P, Q and R? 
(1)
	
A	
	
B	
	
C	
	
D	
P
Q
R
partial osmoconformer
osmoregulator
strict osmoconformer
partial osmoconformer
strict osmoconformer
osmoregulator
osmoregulator
strict osmoconformer
partial osmoconformer
strict osmoconformer
partial osmoconformer
osmoregulator
PMT


--- Page Break ---

*P71934A02628*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
26
 
 
	
	
(ii)	 Explain the advantages for osmoconformers of having cells with solute 
concentrations similar to that of the sea water they live in.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................  
	
(b)	 The table shows the concentration of ions in sea water and in 
some osmoconformers.
Location
Ion concentration / a.u.
sodium
magnesium
calcium
potassium
chloride
Sea water
478
55
11
10
558
Cells of 
osmoconformers
jellyfish
474
53
10
11
sea urchin
474
54
11
10
557
lobster
541
9
12
8
552
	
	
(i)	 Estimate the chloride concentration of the cells of a jellyfish.
(1)
Answer .............................................................. a.u.
PMT


--- Page Break ---

*P71934A02728*
27
 
 
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
	
	
(ii)	 Calculate the percentage difference in the concentration of magnesium ions 
in the lobster compared with the sea urchin.
	
	
	 Give your answer to two decimal places.
(2)
Answer ..............................................................%
	
	
(iii)	 These three animals are osmoconformers even though they have different 
concentrations of each ion in their cells. 
	
	
	 Explain why these three animals can be described as osmoconformers.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(iv)	 Suggest why osmoconformers do not have the same concentration of each 
ion in their cells. 
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
Turn over     
PMT


--- Page Break ---

*P71934A02828*
DO NOT WRITE IN THIS AREA 	
	DO NOT WRITE IN THIS AREA		
	
	 	
	DO NOT WRITE IN THIS AREA
28
 
 
	
	
(v)	 Energy is needed to maintain the concentration of ions inside 
the osmoconformers.
	
	
	 Explain what this energy is being used for.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 9 = 12 marks)
TOTAL FOR PAPER = 80 MARKS
PMT
